With healthcare reform through Congress and signed by the President, there are sure to be changes in the sector’s landscape. We explore some of what we see as the surest winners in your May issue of The Complete Investor. Today we’ll cover some recent earnings reports from healthcare positions in our Growth Portfolio. Our picks are benefiting from an already well-entrenched trend: the proliferation of generic drugs.Read more...